RIVAROXABAN

RIVAROXABAN was reported 208599 times

RIVAROXABAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 816 0.8727
1 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 124 0.6927
2 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 249 0.6640
3 GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC 116 0.5949
4 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1033 0.4591
5 CHRONIC GASTROINTESTINAL BLEEDING 110 0.4314
6 TRUNCUS ARTERIOSUS PERSISTENT 82 0.4121
7 HAEMORRHAGIC EROSIVE GASTRITIS 114 0.3486
8 BASAL GANGLIA HAEMORRHAGE 263 0.3231
9 LOWER GASTROINTESTINAL HAEMORRHAGE 2388 0.3227
10 INTERNAL HAEMORRHAGE 3655 0.3195
11 GASTROINTESTINAL POLYP HAEMORRHAGE 178 0.2942
12 ANTICOAGULATION DRUG LEVEL INCREASED 87 0.2710
13 UPPER GASTROINTESTINAL HAEMORRHAGE 4516 0.2682
14 THALAMUS HAEMORRHAGE 230 0.2644
15 GASTROINTESTINAL HAEMORRHAGE 21673 0.2591
16 EMBOLIC CEREBRAL INFARCTION 163 0.2459
17 HIGH FREQUENCY ABLATION 98 0.2408
18 PERICARDIAL HAEMORRHAGE 523 0.2389
19 ATRIAL THROMBOSIS 484 0.2339
20 HAEMORRHAGIC STROKE 1807 0.2312
21 ADRENAL HAEMORRHAGE 122 0.2182
22 RENAL HAEMORRHAGE 438 0.2151
23 GASTRITIS HAEMORRHAGIC 319 0.2134
24 BLOOD LOSS ANAEMIA 455 0.2007
25 PEPTIC ULCER HAEMORRHAGE 133 0.1908
26 HAEMORRHAGIC TRANSFORMATION STROKE 286 0.1898
27 HAEMORRHAGIC ANAEMIA 829 0.1884
28 HAEMORRHOIDAL HAEMORRHAGE 915 0.1872
29 DYSFUNCTIONAL UTERINE BLEEDING 227 0.1870
30 POST PROCEDURAL HAEMATOMA 314 0.1860
31 CEREBELLAR HAEMORRHAGE 266 0.1860
32 SPLENIC HAEMORRHAGE 93 0.1827
33 EMBOLIC STROKE 596 0.1691
34 ABDOMINAL WALL HAEMATOMA 327 0.1674
35 INTRAVENTRICULAR HAEMORRHAGE 404 0.1622
36 SMALL INTESTINAL HAEMORRHAGE 316 0.1567
37 GASTRIC ULCER HAEMORRHAGE 867 0.1563
38 DUODENAL ULCER HAEMORRHAGE 446 0.1557
39 RENAL HAEMATOMA 80 0.1556
40 SUBCUTANEOUS HAEMATOMA 197 0.1543
41 RETROPERITONEAL HAEMORRHAGE 381 0.1543
42 INCISION SITE HAEMORRHAGE 125 0.1541
43 STEROID DEPENDENCE 131 0.1492
44 CATARRH 132 0.1460
45 HAEMATURIA 4963 0.1448
46 GASTROINTESTINAL ULCER HAEMORRHAGE 158 0.1406
47 HAEMORRHAGIC CEREBRAL INFARCTION 98 0.1396
48 CARDIOVERSION 194 0.1388
49 HAEMORRHAGE INTRACRANIAL 2065 0.1380
50 WOUND HAEMORRHAGE 495 0.1337
51 HAEMORRHAGE URINARY TRACT 328 0.1288
52 SHOCK HAEMORRHAGIC 1037 0.1273
53 TRAUMATIC INTRACRANIAL HAEMORRHAGE 116 0.1262
54 HAEMOTHORAX 363 0.1250
55 OCCULT BLOOD POSITIVE 242 0.1231
56 CEREBRAL HAEMATOMA 410 0.1219
57 RECTAL HAEMORRHAGE 5180 0.1205
58 SUBDURAL HAEMATOMA 1708 0.1192
59 ISCHAEMIC STROKE 2129 0.1192
60 SUBDURAL HAEMORRHAGE 320 0.1168
61 RETROPERITONEAL HAEMATOMA 258 0.1166
62 CEREBRAL ARTERY EMBOLISM 142 0.1165
63 BRAIN STEM HAEMORRHAGE 109 0.1152
64 HAEMATOMA MUSCLE 138 0.1151
65 ARTERIAL HAEMORRHAGE 130 0.1137
66 TRAUMATIC HAEMATOMA 117 0.1089
67 PENILE HAEMORRHAGE 88 0.1078
68 SPLENIC RUPTURE 176 0.1070
69 MYOGLOBIN BLOOD INCREASED 159 0.1039
70 MALLORY-WEISS SYNDROME 131 0.1031
71 LARGE INTESTINAL HAEMORRHAGE 228 0.1015
72 INTRA-ABDOMINAL HAEMATOMA 125 0.1008
73 PERIPHERAL EMBOLISM 115 0.0997
74 POST PROCEDURAL HAEMORRHAGE 1155 0.0991
75 CEREBRAL HAEMORRHAGE 3497 0.0976
76 CARDIAC ABLATION 173 0.0968
77 EXTRADURAL HAEMATOMA 126 0.0952
78 HAEMATOMA 2461 0.0949
79 UTERINE HAEMORRHAGE 404 0.0947
80 OBSTRUCTIVE SLEEP APNOEA SYNDROME 137 0.0939
81 ISCHAEMIC CEREBRAL INFARCTION 108 0.0929
82 EPISTAXIS 6806 0.0909
83 PERITONEAL HAEMORRHAGE 126 0.0908
84 HYPOCHROMIC ANAEMIA 92 0.0907
85 MICROCYTIC ANAEMIA 185 0.0889
86 URINARY BLADDER HAEMORRHAGE 185 0.0878
87 VASCULAR PSEUDOANEURYSM 149 0.0855
88 HYPOVOLAEMIC SHOCK 409 0.0853
89 HAEMOPTYSIS 2380 0.0852
90 MELAENA 1832 0.0832
91 CREATININE RENAL CLEARANCE DECREASED 330 0.0824
92 MUSCLE HAEMORRHAGE 326 0.0812
93 DEEP VEIN THROMBOSIS 5241 0.0806
94 GINGIVAL BLEEDING 1099 0.0804
95 SUBARACHNOID HAEMORRHAGE 818 0.0802
96 HAEMORRHAGIC DIATHESIS 285 0.0800
97 MOUTH HAEMORRHAGE 584 0.0796
98 PHARYNGEAL HAEMORRHAGE 98 0.0795
99 EAR HAEMORRHAGE 161 0.0795
100 IRON DEFICIENCY ANAEMIA 718 0.0777
101 EMBOLISM VENOUS 230 0.0758
102 BURNS SECOND DEGREE 133 0.0757
103 BLOOD URINE PRESENT 1437 0.0756
104 HAEMORRHAGE 7819 0.0747
105 POSTMENOPAUSAL HAEMORRHAGE 193 0.0740
106 PERIPHERAL ARTERY THROMBOSIS 101 0.0719
107 COAGULOPATHY 1198 0.0718
108 CARDIAC VENTRICULAR THROMBOSIS 92 0.0713
109 TRAUMATIC HAEMORRHAGE 134 0.0712
110 PELVIC VENOUS THROMBOSIS 102 0.0711
111 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 623 0.0704
112 PERIPHERAL ARTERY OCCLUSION 98 0.0697
113 INTRACARDIAC THROMBUS 214 0.0697
114 ECCHYMOSIS 478 0.0696
115 PRODUCT MONITORING ERROR 100 0.0692
116 BRAIN NATRIURETIC PEPTIDE INCREASED 211 0.0684
117 ANTIPHOSPHOLIPID SYNDROME 110 0.0684
118 CEREBRAL INFARCTION 1666 0.0681
119 OESOPHAGEAL HAEMORRHAGE 90 0.0680
120 HAEMARTHROSIS 603 0.0672
121 HAEMORRHAGE SUBCUTANEOUS 231 0.0651
122 BLEEDING TIME PROLONGED 78 0.0646
123 CEREBELLAR INFARCTION 109 0.0644
124 PULMONARY EMBOLISM 6046 0.0636
125 INTRA-ABDOMINAL HAEMORRHAGE 151 0.0633
126 THROMBOSIS 5000 0.0621
127 PROCEDURAL HAEMORRHAGE 242 0.0618
128 PROTHROMBIN TIME PROLONGED 367 0.0613
129 THERAPEUTIC PROCEDURE 85 0.0607
130 PRODUCT LABEL ISSUE 410 0.0604
131 VENOUS THROMBOSIS LIMB 123 0.0596
132 CARDIAC TAMPONADE 283 0.0595
133 DRUG PRESCRIBING ERROR 1119 0.0582
134 BLOOD BLISTER 181 0.0579
135 MENORRHAGIA 1132 0.0576
136 PULMONARY HAEMORRHAGE 449 0.0573
137 VASCULAR STENT THROMBOSIS 116 0.0569
138 CONJUNCTIVAL HAEMORRHAGE 212 0.0554
139 PULMONARY THROMBOSIS 604 0.0553
140 TUMOUR HAEMORRHAGE 156 0.0546
141 MENOMETRORRHAGIA 103 0.0540
142 CATHETER SITE HAEMORRHAGE 135 0.0539
143 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 82 0.0534
144 STOMA SITE HAEMORRHAGE 82 0.0532
145 HAEMATEMESIS 1315 0.0518
146 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 258 0.0509
147 GASTRIC HAEMORRHAGE 574 0.0498
148 COMPARTMENT SYNDROME 129 0.0494
149 VENOUS THROMBOSIS 194 0.0494
150 HYPERCOAGULATION 93 0.0488
151 PULMONARY ALVEOLAR HAEMORRHAGE 272 0.0484
152 CARDIAC FAILURE CHRONIC 204 0.0478
153 ARTERIAL THROMBOSIS 90 0.0465
154 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 188 0.0460
155 ATRIAL FIBRILLATION 4480 0.0460
156 INTERNATIONAL NORMALISED RATIO INCREASED 1287 0.0451
157 CEREBRAL ISCHAEMIA 232 0.0450
158 HYPOPNOEA 150 0.0432
159 HEMIPLEGIA 359 0.0431
160 GASTRITIS EROSIVE 199 0.0426
161 INCREASED TENDENCY TO BRUISE 390 0.0423
162 PERIPHERAL ISCHAEMIA 170 0.0416
163 FAECES DISCOLOURED 890 0.0410
164 HAEMATOCHEZIA 2247 0.0407
165 ATRIAL FLUTTER 322 0.0403
166 CARDIAC PACEMAKER INSERTION 239 0.0401
167 ANAL HAEMORRHAGE 112 0.0400
168 PLANTAR FASCIITIS 134 0.0399
169 THROMBOPHLEBITIS SUPERFICIAL 121 0.0399
170 CEREBRAL THROMBOSIS 112 0.0395
171 POTENTIATING DRUG INTERACTION 132 0.0393
172 BRAIN HERNIATION 116 0.0388
173 EMBOLISM 311 0.0374
174 FIBRIN D DIMER INCREASED 133 0.0374
175 ABNORMAL LOSS OF WEIGHT 255 0.0374
176 PRESCRIBED UNDERDOSE 745 0.0373
177 HYPERSENSITIVITY VASCULITIS 97 0.0369
178 TRANSIENT ISCHAEMIC ATTACK 1222 0.0362
179 VITREOUS HAEMORRHAGE 100 0.0362
180 VAGINAL HAEMORRHAGE 1566 0.0360
181 DUODENAL ULCER 253 0.0358
182 RETINAL ARTERY OCCLUSION 90 0.0356
183 ALCOHOL POISONING 95 0.0354
184 ULCER HAEMORRHAGE 240 0.0354
185 ACUTE KIDNEY INJURY 5244 0.0342
186 INFUSION SITE HAEMORRHAGE 112 0.0340
187 THROMBOPHLEBITIS 117 0.0333
188 CEREBROVASCULAR ACCIDENT 5648 0.0333
189 POLYP 218 0.0333
190 DYSPNOEA EXERTIONAL 1246 0.0330
191 EYE HAEMORRHAGE 439 0.0329
192 INTERNATIONAL NORMALISED RATIO ABNORMAL 111 0.0322
193 BRONCHIECTASIS 217 0.0322
194 HAEMOGLOBIN DECREASED 3262 0.0317
195 ORTHOPNOEA 100 0.0314
196 DIASTOLIC DYSFUNCTION 94 0.0304
197 HEMIPARESIS 515 0.0304
198 ACUTE RESPIRATORY FAILURE 584 0.0303
199 NORMOCHROMIC NORMOCYTIC ANAEMIA 91 0.0303
200 ANAEMIA 5772 0.0302
201 IRON DEFICIENCY 134 0.0298
202 CRANIOCEREBRAL INJURY 90 0.0297
203 DUODENITIS 91 0.0296
204 DIVERTICULUM 203 0.0285
205 GLOMERULAR FILTRATION RATE DECREASED 351 0.0285
206 OBSTRUCTIVE AIRWAYS DISORDER 316 0.0284
207 VENTRICULAR HYPOKINESIA 91 0.0283
208 CYSTITIS HAEMORRHAGIC 114 0.0283
209 RIGHT VENTRICULAR FAILURE 197 0.0281
210 CARDIAC MURMUR 243 0.0281
211 LEFT VENTRICULAR FAILURE 96 0.0279
212 CONTUSION 2679 0.0278
213 PETECHIAE 289 0.0277
214 LEFT VENTRICULAR DYSFUNCTION 185 0.0276
215 THROMBOCYTOSIS 101 0.0275
216 LARGE INTESTINE POLYP 187 0.0270
217 PULMONARY ARTERIAL HYPERTENSION 390 0.0269
218 CARDIAC FAILURE ACUTE 179 0.0268
219 PERICARDIAL EFFUSION 618 0.0267
220 RETINAL HAEMORRHAGE 189 0.0265
221 SKIN ABRASION 125 0.0264
222 CAROTID ARTERY OCCLUSION 96 0.0263
223 GASTRIC ULCER 497 0.0261
224 PULMONARY HYPERTENSION 544 0.0261
225 TRANSFUSION 273 0.0260
226 PURPURA 229 0.0259
227 SKIN HAEMORRHAGE 362 0.0244
228 INTESTINAL ISCHAEMIA 134 0.0243
229 RALES 141 0.0243
230 WOUND SECRETION 95 0.0242
231 PAROSMIA 179 0.0237
232 HYDROCEPHALUS 129 0.0237
233 COLITIS ISCHAEMIC 159 0.0235
234 AORTIC STENOSIS 82 0.0235
235 TRICUSPID VALVE INCOMPETENCE 186 0.0234
236 DIVERTICULUM INTESTINAL 102 0.0233
237 CARDIAC OPERATION 200 0.0232
238 CATHETERISATION CARDIAC 103 0.0232
239 CHROMATURIA 523 0.0231
240 GINGIVAL PAIN 183 0.0230
241 EXERCISE TOLERANCE DECREASED 132 0.0229
242 STENT PLACEMENT 183 0.0227
243 TROPONIN INCREASED 170 0.0223
244 CORONARY ARTERY STENOSIS 111 0.0221
245 CARDIAC FAILURE 1766 0.0220
246 RHINITIS 177 0.0219
247 DRUG INTERACTION 3476 0.0219
248 CHRONIC SINUSITIS 82 0.0218
249 LEG AMPUTATION 89 0.0216
250 PRODUCT PRESCRIBING ISSUE 466 0.0214
251 BLOOD IRON DECREASED 252 0.0212
252 VASCULAR DEVICE INFECTION 96 0.0211
253 ACUTE MYOCARDIAL INFARCTION 621 0.0210
254 EXOSTOSIS 192 0.0210
255 PRODUCT SIZE ISSUE 113 0.0210
256 INFUSION SITE ERYTHEMA 177 0.0210
257 LACERATION 194 0.0206
258 HEAD INJURY 649 0.0205
259 INFUSION SITE PAIN 263 0.0204
260 PROSTATOMEGALY 80 0.0203
261 BLOOD PRESSURE SYSTOLIC DECREASED 92 0.0202
262 VARICOSE VEIN 104 0.0201
263 ERYSIPELAS 101 0.0201
264 INFUSION SITE SWELLING 122 0.0194
265 BLOOD PRESSURE DIASTOLIC DECREASED 143 0.0194
266 SENSATION OF FOREIGN BODY 163 0.0193
267 EOSINOPHILIA 338 0.0193
268 HAEMORRHOIDS 375 0.0192
269 AORTIC ANEURYSM 146 0.0192
270 PHLEBITIS 97 0.0189
271 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1341 0.0188
272 ANGINA UNSTABLE 122 0.0188
273 BODY HEIGHT DECREASED 200 0.0187
274 ADVERSE EVENT 1720 0.0186
275 BREATH SOUNDS ABNORMAL 92 0.0186
276 ACUTE CORONARY SYNDROME 154 0.0186
277 FALL 6184 0.0186
278 SKIN NECROSIS 96 0.0185
279 MITRAL VALVE INCOMPETENCE 208 0.0184
280 HAEMATOCRIT DECREASED 364 0.0183
281 PRESYNCOPE 446 0.0183
282 ARRHYTHMIA 864 0.0182
283 HYPERVOLAEMIA 89 0.0180
284 GOUT 323 0.0180
285 BLOOD DISORDER 144 0.0180
286 DIZZINESS POSTURAL 173 0.0178
287 HYPOVOLAEMIA 104 0.0178
288 UROSEPSIS 163 0.0177
289 INCORRECT DOSAGE ADMINISTERED 86 0.0176
290 RENAL IMPAIRMENT 1476 0.0176
291 DIARRHOEA HAEMORRHAGIC 164 0.0175
292 PEMPHIGOID 132 0.0175
293 BLOOD PRESSURE SYSTOLIC INCREASED 339 0.0174
294 URINE ABNORMALITY 79 0.0174
295 OEDEMA PERIPHERAL 2105 0.0173
296 HEART RATE IRREGULAR 387 0.0171
297 CARDIOGENIC SHOCK 245 0.0171
298 APHASIA 515 0.0170
299 HAEMOGLOBIN ABNORMAL 109 0.0169
300 FLUID OVERLOAD 246 0.0169
301 SYNCOPE 1683 0.0168
302 CIRCULATORY COLLAPSE 285 0.0167
303 PERIPHERAL SWELLING 2524 0.0164
304 SKIN LACERATION 178 0.0164
305 TREATMENT NONCOMPLIANCE 891 0.0163
306 RESPIRATORY FAILURE 1182 0.0162
307 LIMB INJURY 440 0.0162
308 FACIAL PARALYSIS 138 0.0162
309 ENDOCARDITIS 83 0.0162
310 PNEUMOTHORAX 254 0.0160
311 HIATUS HERNIA 207 0.0160
312 CONTRAINDICATED PRODUCT ADMINISTERED 483 0.0159
313 URINE ODOUR ABNORMAL 93 0.0158
314 ARTERIOSCLEROSIS CORONARY ARTERY 104 0.0157
315 FLUID RETENTION 796 0.0156
316 EMPHYSEMA 157 0.0155
317 ORTHOSTATIC HYPOTENSION 271 0.0155
318 VENTRICULAR SEPTAL DEFECT 89 0.0155
319 ATRIOVENTRICULAR BLOCK 120 0.0155
320 BRADYCARDIA 823 0.0155
321 SECRETION DISCHARGE 193 0.0154
322 POSTOPERATIVE WOUND INFECTION 104 0.0154
323 HIP SURGERY 83 0.0153
324 OXYGEN SATURATION DECREASED 856 0.0152
325 SUDDEN DEATH 161 0.0152
326 HEART RATE DECREASED 533 0.0152
327 PNEUMONIA ASPIRATION 379 0.0152
328 PRODUCT PRESCRIBING ERROR 361 0.0151
329 HYPOTENSION 3030 0.0151
330 PALLOR 411 0.0151
331 GASTRITIS 395 0.0150
332 HYPERTHYROIDISM 216 0.0149
333 PLEURAL EFFUSION 904 0.0148
334 CARDIAC FLUTTER 96 0.0148
335 HEAVY MENSTRUAL BLEEDING 133 0.0148
336 PRODUCTIVE COUGH 700 0.0146
337 LYMPHOEDEMA 101 0.0146
338 ATRIOVENTRICULAR BLOCK COMPLETE 97 0.0145
339 CARDIAC FAILURE CONGESTIVE 1164 0.0145
340 INFARCTION 99 0.0145
341 HEPATITIS ACUTE 94 0.0144
342 SKIN ATROPHY 83 0.0144
343 COLON CANCER 214 0.0143
344 HEART RATE ABNORMAL 80 0.0143
345 CARDIOMEGALY 175 0.0142
346 LIPASE INCREASED 109 0.0142
347 ELECTROLYTE IMBALANCE 165 0.0142
348 BLOOD PRESSURE DECREASED 943 0.0142
349 OESOPHAGITIS 155 0.0142
350 HAEMODYNAMIC INSTABILITY 108 0.0142
351 BLOOD PRESSURE FLUCTUATION 340 0.0142
352 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 738 0.0141
353 RED BLOOD CELL COUNT DECREASED 404 0.0141
354 C-REACTIVE PROTEIN ABNORMAL 90 0.0140
355 HYPERKALAEMIA 492 0.0140
356 FRUSTRATION TOLERANCE DECREASED 113 0.0140
357 ARTERIOSCLEROSIS 131 0.0139
358 ULCER 221 0.0139
359 FULL BLOOD COUNT DECREASED 279 0.0138
360 CORONARY ARTERY DISEASE 419 0.0138
361 BLADDER DISORDER 137 0.0138
362 BLOOD COUNT ABNORMAL 209 0.0138
363 CLOSTRIDIUM DIFFICILE COLITIS 146 0.0138
364 BODY TEMPERATURE DECREASED 135 0.0137
365 TUBULOINTERSTITIAL NEPHRITIS 256 0.0136
366 RESPIRATORY RATE INCREASED 121 0.0136
367 INTERSTITIAL LUNG DISEASE 659 0.0136
368 CELLULITIS 678 0.0134
369 LIMB DISCOMFORT 415 0.0134
370 HOSPITALISATION 2060 0.0134
371 ANGINA PECTORIS 384 0.0134
372 PERIPHERAL COLDNESS 184 0.0134
373 HYPERTENSIVE CRISIS 149 0.0134
374 BLOOD CREATININE INCREASED 874 0.0134
375 EJECTION FRACTION DECREASED 208 0.0134
376 THROMBOCYTOPENIA 1492 0.0133
377 TOXIC SKIN ERUPTION 134 0.0133
378 PLATELET COUNT INCREASED 173 0.0133
379 RENAL CYST 105 0.0132
380 PULMONARY OEDEMA 589 0.0131
381 IMPAIRED QUALITY OF LIFE 189 0.0131
382 DYSPNOEA 7421 0.0131
383 SEASONAL ALLERGY 185 0.0131
384 RENAL PAIN 137 0.0129
385 PAIN IN JAW 364 0.0128
386 SLEEP APNOEA SYNDROME 245 0.0128
387 RIB FRACTURE 264 0.0128
388 SHOCK 295 0.0128
389 FEELING COLD 356 0.0128
390 MULTIPLE ALLERGIES 100 0.0127
391 SEPTIC SHOCK 550 0.0126
392 DEVICE RELATED INFECTION 193 0.0125
393 SURGERY 735 0.0125
394 TOOTH EXTRACTION 156 0.0125
395 BASAL CELL CARCINOMA 194 0.0124
396 BLOOD UREA INCREASED 208 0.0124
397 PRODUCT PACKAGING ISSUE 118 0.0124
398 LACTIC ACIDOSIS 402 0.0124
399 COVID-19 PNEUMONIA 146 0.0124
400 PARALYSIS 177 0.0124
401 NOCTURIA 150 0.0123
402 VENTRICULAR TACHYCARDIA 204 0.0123
403 HYPOKALAEMIA 567 0.0123
404 MUSCULOSKELETAL CHEST PAIN 190 0.0123
405 BLOOD PRESSURE ABNORMAL 244 0.0123
406 CORONAVIRUS INFECTION 81 0.0122
407 ASTHENIA 4594 0.0122
408 KNEE ARTHROPLASTY 257 0.0122
409 ASPIRATION 133 0.0121
410 DIVERTICULITIS 336 0.0121
411 HYSTERECTOMY 105 0.0121
412 KNEE OPERATION 118 0.0120
413 URINARY RETENTION 398 0.0119
414 DERMATITIS ALLERGIC 149 0.0118
415 CORONARY ARTERY OCCLUSION 162 0.0118
416 FLANK PAIN 110 0.0117
417 MEDICATION ERROR 649 0.0117
418 DECUBITUS ULCER 95 0.0116
419 MUSCULOSKELETAL DISCOMFORT 200 0.0116
420 VERTIGO 708 0.0116
421 OEDEMA 630 0.0116
422 PNEUMONIA 3759 0.0116
423 DISSEMINATED INTRAVASCULAR COAGULATION 163 0.0116
424 ARTERIAL OCCLUSIVE DISEASE 91 0.0116
425 CHEST PAIN 2140 0.0115
426 VASCULITIS 134 0.0115
427 SKIN DISCOLOURATION 528 0.0115
428 FURUNCLE 91 0.0115
429 ADRENAL INSUFFICIENCY 139 0.0114
430 ANAL INCONTINENCE 103 0.0114
431 MASS 160 0.0114
432 FREQUENT BOWEL MOVEMENTS 309 0.0114
433 DYSARTHRIA 430 0.0114
434 SPUTUM DISCOLOURED 108 0.0114
435 BLOOD MAGNESIUM DECREASED 98 0.0113
436 HYPOMAGNESAEMIA 158 0.0113
437 HEART RATE INCREASED 1123 0.0113
438 JOINT INJURY 242 0.0113
439 HYPONATRAEMIA 635 0.0113
440 BLINDNESS UNILATERAL 159 0.0113
441 LUNG DISORDER 550 0.0112
442 DEMENTIA 313 0.0112
443 DIZZINESS 5584 0.0112
444 TRANSAMINASES INCREASED 248 0.0111
445 PRODUCT DOSE OMISSION 727 0.0111
446 DRUG-INDUCED LIVER INJURY 349 0.0111
447 RENAL FAILURE 1475 0.0111
448 HIP FRACTURE 357 0.0111
449 CHEST DISCOMFORT 1130 0.0110
450 URINARY TRACT INFECTION 1881 0.0110
451 BRAIN OEDEMA 139 0.0110
452 LIVER FUNCTION TEST ABNORMAL 319 0.0110
453 GAMMA-GLUTAMYLTRANSFERASE INCREASED 243 0.0110
454 INCORRECT DOSE ADMINISTERED 2502 0.0109
455 JAUNDICE 293 0.0109
456 MUSCLE STRAIN 94 0.0109
457 HEPATOCELLULAR INJURY 154 0.0109
458 ABNORMAL FAECES 89 0.0109
459 PALPITATIONS 1267 0.0108
460 CYSTITIS 343 0.0108
461 CARDIAC DISORDER 995 0.0106
462 GENERAL PHYSICAL HEALTH DETERIORATION 1230 0.0106
463 POLYURIA 87 0.0106
464 RASH MACULO-PAPULAR 236 0.0106
465 HAEMOLYTIC ANAEMIA 95 0.0106
466 TACHYPNOEA 144 0.0106
467 BLOOD ALBUMIN DECREASED 84 0.0106
468 PLATELET COUNT DECREASED 1128 0.0106
469 HIP ARTHROPLASTY 162 0.0106
470 POST PROCEDURAL INFECTION 86 0.0106
471 SKIN ULCER 273 0.0106
472 ILEUS 131 0.0105
473 METASTASES TO LIVER 185 0.0105
474 WOUND 294 0.0105
475 HELICOBACTER INFECTION 108 0.0105
476 DRUG DOSE OMISSION 1734 0.0105
477 GROIN PAIN 92 0.0105
478 LOCALISED INFECTION 253 0.0105
479 PAIN IN EXTREMITY 3075 0.0104
480 MICTURITION URGENCY 119 0.0104
481 DYSURIA 383 0.0104
482 ARTHRITIS 816 0.0104
483 PNEUMONITIS 278 0.0102
484 THYROID DISORDER 157 0.0102
485 DECREASED APPETITE 2364 0.0102
486 DRUG LEVEL INCREASED 168 0.0101
487 WOUND INFECTION 111 0.0101
488 HOSPICE CARE 100 0.0101
489 SEPSIS 1128 0.0101
490 HEPATIC FAILURE 304 0.0101
491 HEPATITIS 258 0.0101
492 HEPATOMEGALY 99 0.0101
493 MULTIPLE ORGAN DYSFUNCTION SYNDROME 285 0.0101
494 SCRATCH 106 0.0100
495 MYOCARDIAL ISCHAEMIA 114 0.0100
496 ALTERED STATE OF CONSCIOUSNESS 217 0.0100
497 HYPOXIA 352 0.0100
498 SCAB 114 0.0100
499 TINNITUS 458 0.0100
500 MACULAR DEGENERATION 119 0.0100
501 CARDIOMYOPATHY 147 0.0099
502 GENERALISED OEDEMA 123 0.0099
503 URINARY INCONTINENCE 294 0.0099
504 RASH PRURITIC 537 0.0099
505 IMPAIRED HEALING 325 0.0099
506 CONFUSIONAL STATE 1598 0.0099
507 SKIN LESION 271 0.0099
508 ACUTE HEPATIC FAILURE 135 0.0099
509 DEHYDRATION 1316 0.0099
510 CHOLESTASIS 189 0.0098
511 PLASMA CELL MYELOMA 384 0.0098
512 CANDIDA INFECTION 166 0.0098
513 PULMONARY FIBROSIS 187 0.0097
514 URINE OUTPUT DECREASED 85 0.0097
515 CLOSTRIDIUM DIFFICILE INFECTION 212 0.0097
516 HEPATIC CIRRHOSIS 182 0.0097
517 NEPHROLITHIASIS 444 0.0097
518 WHEEZING 573 0.0097
519 DERMATITIS CONTACT 110 0.0096
520 TOOTH INFECTION 127 0.0096
521 VENTRICULAR EXTRASYSTOLES 100 0.0096
522 COUGH 2692 0.0096
523 DRUG ERUPTION 170 0.0096
524 WEIGHT FLUCTUATION 100 0.0095
525 BLOOD SODIUM DECREASED 180 0.0095
526 NEPHROPATHY 89 0.0095
527 TOOTH ABSCESS 97 0.0095
528 TASTE DISORDER 193 0.0095
529 NEUROPATHY PERIPHERAL 903 0.0095
530 DYSPHONIA 555 0.0095
531 MUSCULAR WEAKNESS 1078 0.0095
532 BLOOD POTASSIUM DECREASED 285 0.0095
533 AGRANULOCYTOSIS 176 0.0095
534 PULMONARY MASS 141 0.0095
535 WEIGHT DECREASED 2636 0.0094
536 SPINAL PAIN 110 0.0094
537 ACCIDENTAL OVERDOSE 343 0.0094
538 HYPOKINESIA 136 0.0094
539 SQUAMOUS CELL CARCINOMA 88 0.0093
540 OSTEOARTHRITIS 396 0.0093
541 BRAIN INJURY 93 0.0093
542 BACK PAIN 2150 0.0092
543 ASCITES 272 0.0092
544 RETINAL DETACHMENT 85 0.0092
545 BLOOD THYROID STIMULATING HORMONE INCREASED 85 0.0092
546 SWOLLEN TONGUE 288 0.0092
547 CARDIAC ARREST 761 0.0092
548 ELECTROCARDIOGRAM QT PROLONGED 331 0.0092
549 OFF LABEL USE 8056 0.0092
550 COMA 438 0.0092
551 LOSS OF CONSCIOUSNESS 1178 0.0092
552 SKIN INFECTION 103 0.0092
553 SPEECH DISORDER 480 0.0092
554 GAIT INABILITY 306 0.0091
555 TACHYCARDIA 812 0.0091
556 DELIRIUM 316 0.0091
557 PULMONARY CONGESTION 120 0.0091
558 HEAD DISCOMFORT 161 0.0091
559 IMPAIRED WORK ABILITY 194 0.0091
560 EATING DISORDER 193 0.0091
561 HERNIA 175 0.0090
562 GASTROOESOPHAGEAL REFLUX DISEASE 728 0.0090
563 C-REACTIVE PROTEIN INCREASED 329 0.0090
564 MUSCULOSKELETAL PAIN 472 0.0090
565 ATELECTASIS 87 0.0090
566 VENTRICULAR FIBRILLATION 100 0.0090
567 DECREASED ACTIVITY 97 0.0090
568 CHOLECYSTITIS 107 0.0090
569 BEDRIDDEN 118 0.0090
570 DIARRHOEA 5790 0.0090
571 BLOOD TEST ABNORMAL 126 0.0090
572 NEOPLASM 103 0.0090
573 JOINT SWELLING 1081 0.0089
574 TOOTH DISORDER 199 0.0089
575 NIGHTMARE 309 0.0089
576 UNRESPONSIVE TO STIMULI 230 0.0089
577 ABDOMINAL DISTENSION 929 0.0089
578 SINUS BRADYCARDIA 86 0.0089
579 POOR VENOUS ACCESS 92 0.0089
580 ACCIDENT 106 0.0089
581 BALANCE DISORDER 767 0.0089
582 RETCHING 189 0.0089
583 HEPATIC CYTOLYSIS 113 0.0089
584 PANCYTOPENIA 494 0.0088
585 BRONCHOSPASM 126 0.0088
586 MYOCARDIAL INFARCTION 1538 0.0088
587 CONSTIPATION 1922 0.0088
588 SINUS CONGESTION 119 0.0088
589 CARDIO-RESPIRATORY ARREST 367 0.0088
590 BRONCHITIS 648 0.0087
591 UNDERDOSE 638 0.0087
592 FATIGUE 6801 0.0087
593 ABDOMINAL DISCOMFORT 1465 0.0087
594 BLOOD PRESSURE INCREASED 1334 0.0087
595 ROTATOR CUFF SYNDROME 112 0.0087
596 TOOTH FRACTURE 96 0.0087
597 JOINT DISLOCATION 92 0.0087
598 UPPER LIMB FRACTURE 173 0.0087
599 SCIATICA 138 0.0086
600 RESPIRATORY TRACT INFECTION 223 0.0086
601 THERAPY CHANGE 84 0.0085
602 MOTOR DYSFUNCTION 87 0.0085
603 LOWER RESPIRATORY TRACT INFECTION 388 0.0085
604 DYSPEPSIA 835 0.0085
605 LETHARGY 487 0.0085
606 GALLBLADDER DISORDER 151 0.0085
607 SPINAL OPERATION 104 0.0084
608 DIPLOPIA 219 0.0084
609 MALNUTRITION 94 0.0084
610 LEUKOCYTOSIS 152 0.0084
611 HYPERTENSION 1776 0.0084
612 GAIT DISTURBANCE 1601 0.0084
613 INTENTIONAL PRODUCT USE ISSUE 732 0.0083
614 HYPOACUSIS 359 0.0083
615 FULL BLOOD COUNT ABNORMAL 88 0.0083
616 DEVICE OCCLUSION 117 0.0083
617 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1497 0.0083
618 METASTASES TO BONE 136 0.0083
619 DRUG LEVEL DECREASED 84 0.0082
620 FEEDING DISORDER 167 0.0082
621 NECK PAIN 460 0.0082
622 RESPIRATORY DISTRESS 227 0.0082
623 ARTHROPATHY 457 0.0082
624 SKIN CANCER 177 0.0082
625 CHRONIC KIDNEY DISEASE 624 0.0082
626 MALAISE 3592 0.0082
627 SARS-COV-2 TEST POSITIVE 108 0.0082
628 ENCEPHALOPATHY 200 0.0081
629 ALOPECIA 1595 0.0081
630 TOOTHACHE 147 0.0081
631 OSTEOPOROSIS 334 0.0081
632 CATARACT 483 0.0081
633 RASH MACULAR 283 0.0081
634 RASH GENERALISED 208 0.0080
635 PRODUCT USE IN UNAPPROVED INDICATION 1987 0.0080
636 PRURITUS GENERALISED 173 0.0080
637 BLOOD BILIRUBIN INCREASED 216 0.0080
638 LIGAMENT SPRAIN 79 0.0080
639 MUSCULOSKELETAL DISORDER 152 0.0080
640 AGEUSIA 199 0.0080
641 FEMUR FRACTURE 247 0.0080
642 PRODUCT ADMINISTRATION ERROR 161 0.0080
643 NASAL CONGESTION 468 0.0080
644 FLATULENCE 451 0.0079
645 RESPIRATORY TRACT CONGESTION 126 0.0079
646 ADVERSE DRUG REACTION 711 0.0079
647 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 380 0.0079
648 METASTASES TO CENTRAL NERVOUS SYSTEM 102 0.0079
649 SMALL INTESTINAL OBSTRUCTION 97 0.0079
650 ABDOMINAL PAIN 1820 0.0078
651 MUSCLE SPASMS 1434 0.0078
652 POOR QUALITY SLEEP 168 0.0078
653 RHABDOMYOLYSIS 325 0.0078
654 ABDOMINAL PAIN UPPER 1603 0.0078
655 SPLENOMEGALY 91 0.0078
656 HEADACHE 4859 0.0077
657 POLLAKIURIA 323 0.0077
658 HYPERSOMNIA 222 0.0077
659 NEURALGIA 188 0.0077
660 LUNG INFECTION 120 0.0077
661 NEOPLASM MALIGNANT 513 0.0077
662 DRY THROAT 78 0.0077
663 DISORIENTATION 304 0.0077
664 BLOOD ALKALINE PHOSPHATASE INCREASED 190 0.0076
665 TENDON RUPTURE 94 0.0076
666 COLITIS 288 0.0076
667 SWELLING 707 0.0075
668 GASTROENTERITIS VIRAL 136 0.0075
669 UPPER RESPIRATORY TRACT INFECTION 347 0.0075
670 ROAD TRAFFIC ACCIDENT 314 0.0075
671 ATAXIA 89 0.0075
672 SYSTEMIC LUPUS ERYTHEMATOSUS 266 0.0075
673 PARAESTHESIA ORAL 108 0.0075
674 HYPOAESTHESIA 1119 0.0075
675 INCONTINENCE 79 0.0075
676 OBESITY 119 0.0075
677 BLOOD LACTATE DEHYDROGENASE INCREASED 118 0.0074
678 DRY MOUTH 603 0.0074
679 ANKLE FRACTURE 115 0.0074
680 SENSORY DISTURBANCE 119 0.0074
681 PARAESTHESIA 1163 0.0074
682 HYPOTHYROIDISM 236 0.0074
683 MYALGIA 1255 0.0074
684 EXTRA DOSE ADMINISTERED 298 0.0073
685 LOCAL SWELLING 128 0.0073
686 STAPHYLOCOCCAL INFECTION 242 0.0073
687 SPINAL FRACTURE 147 0.0073
688 BACTERAEMIA 87 0.0073
689 COVID-19 1283 0.0073
690 HALLUCINATION 550 0.0073
691 INTESTINAL OBSTRUCTION 275 0.0073
692 BLISTER 408 0.0073
693 ECZEMA 380 0.0073
694 RESPIRATORY DISORDER 217 0.0072
695 WHITE BLOOD CELL COUNT DECREASED 785 0.0072
696 MENTAL STATUS CHANGES 201 0.0072
697 JOINT RANGE OF MOTION DECREASED 97 0.0072
698 RED BLOOD CELL SEDIMENTATION RATE INCREASED 80 0.0072
699 METABOLIC ACIDOSIS 231 0.0072
700 LABORATORY TEST ABNORMAL 213 0.0072
701 BLOOD POTASSIUM INCREASED 117 0.0072
702 BLOOD CALCIUM DECREASED 81 0.0072
703 LUNG NEOPLASM MALIGNANT 296 0.0072
704 GASTROENTERITIS 105 0.0072
705 NASOPHARYNGITIS 1325 0.0072
706 DEATH 6190 0.0072
707 GASTRIC DISORDER 246 0.0072
708 APHONIA 100 0.0072
709 VISUAL IMPAIRMENT 883 0.0071
710 RESTLESS LEGS SYNDROME 129 0.0071
711 RASH ERYTHEMATOUS 339 0.0071
712 MOUTH ULCERATION 149 0.0071
713 CARPAL TUNNEL SYNDROME 99 0.0071
714 DENTAL CARIES 78 0.0070
715 PROSTATIC SPECIFIC ANTIGEN INCREASED 97 0.0070
716 POST PROCEDURAL COMPLICATION 135 0.0070
717 HYPERLIPIDAEMIA 84 0.0070
718 RASH 3062 0.0070
719 EPILEPSY 214 0.0070
720 MYELODYSPLASTIC SYNDROME 101 0.0070
721 MEMORY IMPAIRMENT 953 0.0069
722 NAUSEA 5484 0.0069
723 DYSPHAGIA 656 0.0069
724 COMPLICATION ASSOCIATED WITH DEVICE 100 0.0069
725 DYSGEUSIA 511 0.0069
726 COLD SWEAT 121 0.0069
727 CYST 85 0.0068
728 VOMITING 3214 0.0068
729 BACK DISORDER 111 0.0068
730 COLITIS ULCERATIVE 305 0.0068
731 ARTHRALGIA 2837 0.0068
732 LOWER LIMB FRACTURE 131 0.0068
733 HEPATIC ENZYME INCREASED 464 0.0068
734 THERAPY CESSATION 349 0.0068
735 IMMUNODEFICIENCY 101 0.0068
736 RENAL DISORDER 315 0.0068
737 PRODUCT USE ISSUE 1267 0.0067
738 BLINDNESS 274 0.0067
739 DEPRESSED LEVEL OF CONSCIOUSNESS 266 0.0067
740 HYPOCALCAEMIA 127 0.0067
741 WEIGHT INCREASED 1501 0.0067
742 HALLUCINATION, VISUAL 141 0.0067
743 DISABILITY 132 0.0067
744 PRODUCT USE COMPLAINT 105 0.0067
745 HYPERCALCAEMIA 82 0.0066
746 BONE DISORDER 121 0.0066
747 ABASIA 164 0.0066
748 INFLUENZA 740 0.0066
749 PRODUCT DOSE OMISSION ISSUE 1948 0.0066
750 COGNITIVE DISORDER 309 0.0066
751 POLYNEUROPATHY 79 0.0066
752 DRUG ADMINISTRATION ERROR 202 0.0066
753 APATHY 96 0.0066
754 ABDOMINAL PAIN LOWER 166 0.0066
755 HEPATIC FUNCTION ABNORMAL 245 0.0066
756 INJURY 461 0.0066
757 HYPOPHAGIA 167 0.0065
758 PRURITUS 2506 0.0065
759 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 167 0.0065
760 PYREXIA 2230 0.0064
761 PRODUCT PHYSICAL ISSUE 130 0.0064
762 FEELING ABNORMAL 1542 0.0064
763 ORAL PAIN 144 0.0064
764 RENAL INJURY 191 0.0064
765 BURSITIS 78 0.0064
766 CYANOSIS 101 0.0064
767 SKIN DISORDER 214 0.0064
768 BONE PAIN 375 0.0064
769 STOMATITIS 388 0.0064
770 ACUTE RESPIRATORY DISTRESS SYNDROME 113 0.0064
771 DEAFNESS 167 0.0064
772 WHITE BLOOD CELL COUNT INCREASED 245 0.0064
773 PERICARDITIS 107 0.0064
774 ALANINE AMINOTRANSFERASE INCREASED 390 0.0063
775 CHOLELITHIASIS 208 0.0063
776 HEPATIC STEATOSIS 118 0.0063
777 LIVER FUNCTION TEST INCREASED 136 0.0063
778 FUNGAL INFECTION 211 0.0063
779 NEOPLASM PROGRESSION 220 0.0063
780 SINUSITIS 648 0.0063
781 MOBILITY DECREASED 454 0.0063
782 EYE DISORDER 207 0.0063
783 LIVER DISORDER 279 0.0063
784 FRACTURE 119 0.0063
785 HYPERHIDROSIS 808 0.0063
786 BACTERIAL INFECTION 117 0.0063
787 DIABETES MELLITUS 477 0.0063
788 ERUCTATION 121 0.0062
789 HYPOAESTHESIA ORAL 94 0.0062
790 GLAUCOMA 120 0.0062
791 HYPERGLYCAEMIA 227 0.0062
792 SOMNOLENCE 1248 0.0062
793 FOOT FRACTURE 117 0.0062
794 DYSSTASIA 180 0.0062
795 ORAL CANDIDIASIS 81 0.0061
796 MUSCULOSKELETAL STIFFNESS 537 0.0061
797 FIBROMYALGIA 149 0.0061
798 EAR PAIN 119 0.0061
799 SOPOR 81 0.0061
800 GASTROINTESTINAL DISORDER 545 0.0061
801 HYPOGLYCAEMIA 295 0.0061
802 LYMPHADENOPATHY 215 0.0061
803 LIVER INJURY 149 0.0061
804 ILLNESS 622 0.0060
805 CARDIOVASCULAR DISORDER 153 0.0060
806 KIDNEY INFECTION 118 0.0060
807 AMNESIA 391 0.0060
808 SLEEP DISORDER 424 0.0060
809 BODY TEMPERATURE INCREASED 122 0.0060
810 INFLAMMATION 307 0.0059
811 JOINT STIFFNESS 156 0.0059
812 TENDONITIS 92 0.0059
813 OROPHARYNGEAL PAIN 550 0.0059
814 EYE SWELLING 221 0.0059
815 BURNING SENSATION 416 0.0059
816 MUSCLE TIGHTNESS 96 0.0059
817 GLYCOSYLATED HAEMOGLOBIN INCREASED 149 0.0059
818 CONDITION AGGRAVATED 1780 0.0058
819 TREATMENT FAILURE 485 0.0058
820 SKIN FISSURES 114 0.0058
821 LEUKOPENIA 291 0.0058
822 ASPARTATE AMINOTRANSFERASE INCREASED 308 0.0058
823 DRUG INTOLERANCE 556 0.0058
824 FACE OEDEMA 97 0.0057
825 INSOMNIA 1532 0.0057
826 SINUS DISORDER 113 0.0057
827 MIGRAINE 544 0.0057
828 VISION BLURRED 781 0.0057
829 OSTEOMYELITIS 103 0.0057
830 SEIZURE 656 0.0057
831 FEBRILE NEUTROPENIA 376 0.0057
832 SWELLING FACE 369 0.0057
833 LYMPHOCYTE COUNT DECREASED 100 0.0057
834 MENTAL IMPAIRMENT 137 0.0056
835 PANCREATITIS ACUTE 127 0.0056
836 END STAGE RENAL DISEASE 103 0.0056
837 TYPE 2 DIABETES MELLITUS 190 0.0056
838 CHOKING 110 0.0056
839 STEVENS-JOHNSON SYNDROME 125 0.0056
840 NIGHT SWEATS 181 0.0056
841 HOT FLUSH 423 0.0056
842 CHILLS 657 0.0056
843 PANCREATITIS 296 0.0056
844 LIP SWELLING 186 0.0056
845 ABSCESS 89 0.0056
846 EYE PAIN 312 0.0055
847 TREMOR 915 0.0055
848 RHINORRHOEA 353 0.0055
849 ASTHMA 617 0.0055
850 BLOOD CREATINE PHOSPHOKINASE INCREASED 157 0.0054
851 WRONG TECHNIQUE IN DRUG USAGE PROCESS 198 0.0054
852 HERPES ZOSTER 313 0.0054
853 RASH PAPULAR 122 0.0054
854 PAIN 3339 0.0054
855 RENAL FAILURE ACUTE 230 0.0054
856 OCULAR HYPERAEMIA 256 0.0054
857 SCAR 92 0.0054
858 DISCOMFORT 327 0.0054
859 RESTLESSNESS 196 0.0054
860 SNEEZING 120 0.0053
861 NEUTROPENIA 724 0.0053
862 VIRAL INFECTION 177 0.0053
863 MIDDLE INSOMNIA 99 0.0053
864 THROAT IRRITATION 237 0.0053
865 MOVEMENT DISORDER 169 0.0053
866 INTERVERTEBRAL DISC PROTRUSION 115 0.0053
867 FEAR 141 0.0052
868 URTICARIA 878 0.0052
869 UNEVALUABLE EVENT 396 0.0052
870 BRAIN FOG 82 0.0052
871 IRRITABLE BOWEL SYNDROME 112 0.0052
872 INFECTION 756 0.0052
873 ERYTHEMA 1071 0.0052
874 DEPRESSED MOOD 273 0.0052
875 INTENTIONAL DOSE OMISSION 147 0.0052
876 MALIGNANT NEOPLASM PROGRESSION 528 0.0052
877 DISTURBANCE IN ATTENTION 278 0.0051
878 THERAPEUTIC RESPONSE UNEXPECTED 231 0.0051
879 NERVOUSNESS 268 0.0051
880 FEELING HOT 314 0.0051
881 THERAPY NON-RESPONDER 228 0.0051
882 PRODUCT AVAILABILITY ISSUE 114 0.0050
883 DEPRESSION 1137 0.0050
884 INTENTIONAL OVERDOSE 319 0.0050
885 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1000 0.0049
886 NEUTROPHIL COUNT DECREASED 199 0.0049
887 INCORRECT PRODUCT ADMINISTRATION DURATION 105 0.0048
888 PRODUCT DOSE OMISSION IN ERROR 135 0.0048
889 DISEASE PROGRESSION 559 0.0047
890 ERECTILE DYSFUNCTION 121 0.0047
891 PRESCRIBED OVERDOSE 91 0.0047
892 SKIN EXFOLIATION 396 0.0047
893 SEROTONIN SYNDROME 90 0.0047
894 THERAPY INTERRUPTED 334 0.0047
895 MUSCLE TWITCHING 106 0.0046
896 PRODUCT DISPENSING ERROR 100 0.0046
897 PROTEINURIA 87 0.0046
898 LACRIMATION INCREASED 138 0.0046
899 DRUG INEFFECTIVE 6005 0.0046
900 HYPERSENSITIVITY 840 0.0045
901 ANGIOEDEMA 200 0.0045
902 FLUSHING 458 0.0045
903 ANXIETY 1280 0.0045
904 CYTOKINE RELEASE SYNDROME 90 0.0045
905 NERVOUS SYSTEM DISORDER 139 0.0044
906 TOXICITY TO VARIOUS AGENTS 747 0.0044
907 BLOOD CHOLESTEROL INCREASED 204 0.0044
908 DYSKINESIA 177 0.0044
909 INCREASED APPETITE 83 0.0043
910 MENTAL DISORDER 189 0.0043
911 DERMATITIS 91 0.0043
912 INTENTIONAL PRODUCT MISUSE 376 0.0043
913 SUICIDE ATTEMPT 260 0.0043
914 THINKING ABNORMAL 79 0.0042
915 EAR INFECTION 112 0.0042
916 RESPIRATORY ARREST 115 0.0042
917 MUCOSAL INFLAMMATION 109 0.0042
918 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 97 0.0042
919 NEEDLE ISSUE 121 0.0042
920 PANIC ATTACK 150 0.0041
921 BLOOD GLUCOSE DECREASED 196 0.0041
922 DIABETIC KETOACIDOSIS 97 0.0040
923 COMPLETED SUICIDE 336 0.0040
924 VISUAL ACUITY REDUCED 130 0.0039
925 ABNORMAL DREAMS 108 0.0039
926 DEVICE DISLOCATION 169 0.0039
927 AGITATION 285 0.0039
928 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 276 0.0039
929 PROCEDURAL PAIN 107 0.0039
930 INFLUENZA LIKE ILLNESS 315 0.0038
931 INFUSION RELATED REACTION 250 0.0038
932 DISEASE RECURRENCE 179 0.0038
933 EXPIRED PRODUCT ADMINISTERED 125 0.0038
934 BLOOD GLUCOSE INCREASED 678 0.0036
935 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 197 0.0036
936 THROAT TIGHTNESS 97 0.0036
937 DRY EYE 179 0.0036
938 DRY SKIN 475 0.0036
939 PAIN OF SKIN 95 0.0035
940 MOOD ALTERED 96 0.0035
941 DRUG RESISTANCE 90 0.0035
942 OSTEONECROSIS OF JAW 85 0.0034
943 INJECTION SITE HAEMORRHAGE 271 0.0034
944 RHEUMATOID ARTHRITIS 383 0.0034
945 OVERDOSE 706 0.0033
946 INJECTION SITE MASS 118 0.0032
947 PSORIATIC ARTHROPATHY 129 0.0032
948 ILL-DEFINED DISORDER 189 0.0031
949 ANAPHYLACTIC SHOCK 80 0.0031
950 ANAPHYLACTIC REACTION 171 0.0031
951 THERAPEUTIC PRODUCT EFFECT DECREASED 138 0.0031
952 DRUG EFFECT INCOMPLETE 111 0.0031
953 PANCREATIC CARCINOMA 88 0.0030
954 EYE PRURITUS 101 0.0030
955 EYE IRRITATION 167 0.0029
956 PREMATURE BABY 86 0.0029
957 EMOTIONAL DISORDER 87 0.0028
958 PRODUCT SUBSTITUTION ISSUE 161 0.0028
959 ABNORMAL BEHAVIOUR 107 0.0027
960 INJECTION SITE BRUISING 212 0.0027
961 ACNE 188 0.0025
962 OSTEONECROSIS 81 0.0025
963 BLADDER CANCER 145 0.0025
964 AGGRESSION 121 0.0024
965 EXPOSURE DURING PREGNANCY 147 0.0024
966 IRRITABILITY 139 0.0023
967 PSORIASIS 294 0.0022
968 DEVICE LEAKAGE 97 0.0022
969 PRODUCT QUALITY ISSUE 303 0.0022
970 MYELOSUPPRESSION 79 0.0022
971 CRYING 79 0.0022
972 SUICIDAL IDEATION 195 0.0021
973 DEVICE MALFUNCTION 148 0.0021
974 PROSTATE CANCER 166 0.0021
975 SKIN IRRITATION 94 0.0020
976 DEVICE ISSUE 182 0.0020
977 BREAST CANCER 183 0.0020
978 MULTIPLE SCLEROSIS 87 0.0018
979 MATERNAL EXPOSURE DURING PREGNANCY 159 0.0018
980 THERAPEUTIC RESPONSE DECREASED 107 0.0018
981 INJECTION SITE PAIN 510 0.0017
982 FOETAL EXPOSURE DURING PREGNANCY 132 0.0016
983 INJECTION SITE PRURITUS 107 0.0016
984 PRODUCT STORAGE ERROR 121 0.0014
985 MULTIPLE SCLEROSIS RELAPSE 92 0.0013
986 EMOTIONAL DISTRESS 159 0.0013
987 INJECTION SITE SWELLING 100 0.0013
988 SKIN BURNING SENSATION 91 0.0013
989 INJECTION SITE ERYTHEMA 155 0.0012
990 ACCIDENTAL EXPOSURE TO PRODUCT 122 0.0012
991 NO ADVERSE EVENT 186 0.0010